The effect of COVID-19 vaccination on anticoagulation stability in adolescents and young adults using vitamin K antagonists()

INTRODUCTION: The European Medicine Agency has authorized COVID-19 vaccination in adolescents and young adults (AYAs) from 12 years onwards. In elderly vitamin K antagonist (VKA) users, COVID-19 vaccination has been associated with an increased risk of supra- and subtherapeutic INRs. Whether this as...

Descripción completa

Detalles Bibliográficos
Autores principales: Visser, Chantal, Yousefi, Arjen, Nierman, Melchior C., Huisman, Menno V., Gulpen, Anouk J.W., van Ommen, C. Heleen, Kruip, Marieke J.H.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258126/
https://www.ncbi.nlm.nih.gov/pubmed/37321159
http://dx.doi.org/10.1016/j.thromres.2023.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258126/
https://www.ncbi.nlm.nih.gov/pubmed/37321159
http://dx.doi.org/10.1016/j.thromres.2023.06.005

Ejemplares similares